Stefanie Reuter
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Stefanie Reuter has a total of 120 co-authors. Here are the top co-authors by number of shared publications:
- Ralf Mrowka
Department of Internal Medicine III, Experimental Nephrology, Jena University Hospital, Jena, Germany
24 shared publications - Mihály Józsi
Department of Immunology, ELTE Eötvös Loránd University, Budapest, Hungary
10 shared publications Pilar Sánchez-Corral
CIBERER U754, Madrid, Spain; Unidad de Investigación, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain
5 shared publications- Xinlai Cheng
Buchmann Institute for Molecular Life Sciences Johann Wolfgang Goethe‐Universität Frankfurt am Main Max‐von‐Laue‐Str. 15 60438 Frankfurt am Main Deutschland
5 shared publications - Stefan Wölfl
Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, Im Neuenheimer Feld 364, 69120 Heidelberg, Germany
4 shared publications - Jan Hartung
Institute for Physiology, Faculty of Medicine, University of Freiburg, Freiburg, Germany
3 shared publications
Latest Publications
- Open Access
- 13 September 2026
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 48 (9) , 934
Metformin Attenuates the High-Glucose Effect on MORG1 Expression in HEK293 Cells
Reduced expression of MAPK organiser 1 (MORG1) exerts renoprotective effects in MORG1+/− mice in models of type 1 and type 2 diabetes. To investigate the regulation of MORG1 expression, we generated endogenous hMORG1-luciferase-tagged HEK293 cells carrying a firefly luciferase reporter inserted downstream of the human MORG1 gene using the CRISPR/Cas9 method. This study analysed the time-dependent effects of 20 mM D-glucose on MORG1-luciferase activity and examined whether 20 µM metformin influences MORG1 expression. HEK293 cells were genomically modified using CRISPR/Cas9 to insert the firefly luciferase gene downstream of MORG1. Stable clones were selected with puromycin. The influence of D-glucose concentration on MORG1 expression was analysed in a dose- and time-dependent manner. Luciferase assays assessed MORG1 transcriptional activity, while Western blotting determined protein expression. qRT-PCR was used to assess MORG1 mRNA levels. The pharmacological effect of metformin was evaluated in parental and tagged HEK293 cells and TKPTS cells, simultaneously exposed to 5.5 mM or 20 mM D-glucose in the presence or absence of 20 µM metformin. High glucose significantly increased luciferase activity and MORG1 protein expression compared with 5.5 mM glucose controls. Time course experiments demonstrated significant induction of MORG1 transcription, confirmed by corresponding increases in protein levels. Metformin treatment significantly reduced glucose-induced luciferase activity, MORG1 mRNA levels, and MORG1 protein expression at 24 h. Analyses of TKPTS cells show that 20 mM D-glucose elevated Morg1 mRNA levels, while this induction was attenuated in the presence of 20 µM metformin. High glucose induces time-dependent upregulation of MORG1 transcription and protein expression in MORG1-luciferase-tagged HEK293 cells. Metformin application attenuates, but does not fully prevent, glucose-induced MORG1 mRNA and protein expression.
- 13 September 2026
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 48 (9) , 934
Open AccessMetformin Attenuates the High-Glucose Effect on MORG1 Expression in HEK293 Cells
Reduced expression of MAPK organiser 1 (MORG1) exerts renoprotective effects in MORG1+/− mice in models of type 1 and type 2 diabetes. To investigate the regulation of MORG1 expression, we generated endogenous hMORG1-luciferase-tagged HEK293 cells carrying a firefly luciferase reporter inserted downstream of the human MORG1 gene using the CRISPR/Cas9 method. This study analysed the time-dependent effects of 20 mM D-glucose on MORG1-luciferase activity and examined whether 20 µM metformin influences MORG1 expression. HEK293 cells were genomically modified using CRISPR/Cas9 to insert the firefly luciferase gene downstream of MORG1. Stable clones were selected with puromycin. The influence of D-glucose concentration on MORG1 expression was analysed in a dose- and time-dependent manner. Luciferase assays assessed MORG1 transcriptional activity, while Western blotting determined protein expression. qRT-PCR was used to assess MORG1 mRNA levels. The pharmacological effect of metformin was evaluated in parental and tagged HEK293 cells and TKPTS cells, simultaneously exposed to 5.5 mM or 20 mM D-glucose in the presence or absence of 20 µM metformin. High glucose significantly increased luciferase activity and MORG1 protein expression compared with 5.5 mM glucose controls. Time course experiments demonstrated significant induction of MORG1 transcription, confirmed by corresponding increases in protein levels. Metformin treatment significantly reduced glucose-induced luciferase activity, MORG1 mRNA levels, and MORG1 protein expression at 24 h. Analyses of TKPTS cells show that 20 mM D-glucose elevated Morg1 mRNA levels, while this induction was attenuated in the presence of 20 µM metformin. High glucose induces time-dependent upregulation of MORG1 transcription and protein expression in MORG1-luciferase-tagged HEK293 cells. Metformin application attenuates, but does not fully prevent, glucose-induced MORG1 mRNA and protein expression.
- Open Access
Sub-Millivolt Voltage Imaging Reveals Gap Junction-Mediated Bioelectric Contact Inhibition
Sub-millivolt membrane potential ( V m ) dynamics in multicellular non-excitable networks have remained largely invisible due to a lack of sufficiently sensitive imaging tools. Here, we introduce rEstus2s, a next-generation genetically encoded voltage indicator that overcomes this barrier by enabling high-resolution V m imaging across the full physiological resting V m range (-100 to 0 mV). Using rEstus2s, we uncover bioelectric contact inhibition (BCI), a fundamental biophysical principle where gap junction coupling acts as a passive noise filter to stabilize V m . We demonstrate that the time-dependent variance of V m (electrical volatility) relative to the number of cells ( n ) in a network follows a 1/ n scaling law, reflecting a transition from stochastic single-cell behavior to collective electrical stability. While Ca 2+ -activated oncogenic ion channels, including ANO1 and K Ca 3.1, promote pronounced electrical volatility in isolated cells, BCI effectively attenuates volatility in electrically coupled networks. Disruption of gap junction coupling in cancer cells abolishes BCI and restores high electrical volatility. These findings establish a unifying biophysical framework for understanding how multicellularity maintains electrical homeostasis in health and disease. Graphical
Open AccessSub-Millivolt Voltage Imaging Reveals Gap Junction-Mediated Bioelectric Contact Inhibition
Sub-millivolt membrane potential ( V m ) dynamics in multicellular non-excitable networks have remained largely invisible due to a lack of sufficiently sensitive imaging tools. Here, we introduce rEstus2s, a next-generation genetically encoded voltage indicator that overcomes this barrier by enabling high-resolution V m imaging across the full physiological resting V m range (-100 to 0 mV). Using rEstus2s, we uncover bioelectric contact inhibition (BCI), a fundamental biophysical principle where gap junction coupling acts as a passive noise filter to stabilize V m . We demonstrate that the time-dependent variance of V m (electrical volatility) relative to the number of cells ( n ) in a network follows a 1/ n scaling law, reflecting a transition from stochastic single-cell behavior to collective electrical stability. While Ca 2+ -activated oncogenic ion channels, including ANO1 and K Ca 3.1, promote pronounced electrical volatility in isolated cells, BCI effectively attenuates volatility in electrically coupled networks. Disruption of gap junction coupling in cancer cells abolishes BCI and restores high electrical volatility. These findings establish a unifying biophysical framework for understanding how multicellularity maintains electrical homeostasis in health and disease. Graphical
- Open Access
- 4 June 2025
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 53 (W1) , W238-W244
Diffdigester.uni-jena.de: a tool for optimized selection of restriction enzymes for plasmid identification in cloning procedures
Differential digests, also known as test or diagnostic digests, are a standard method in molecular cloning to verify whether a picked clone is indeed the target plasmid or not. However, finding the optimal restriction enzyme for a differential digest by hand may be challenging and time-consuming. To address this problem, we created diffdigester.uni-jena.de (https://diffdigester.uni-jena.de), a free online tool to easily find such enzymes. This tool uses regular expressions to find the restriction sites in the DNA sequences given by the user. It then calculates and displays the resulting fragments on a simulated gel for each enzyme, allowing for easy comparison between the different enzymes. The user can sort these gels alphabetically by enzyme name or by dissimilarity of the restriction patterns between the given DNA sequences. This way, the most distinct pattern is shown first, which gives the most useful enzyme to distinguish between wanted and unwanted ligation products. In fact, it also works on completely unrelated sequences, expanding its possible applications. Thus, diffdigester.uni-jena.de is a fast, reliable, and free-to-use tool to help researchers plan differential digests for verifying their ligation products.
- 4 June 2025
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 53 (W1) , W238-W244
Open AccessDiffdigester.uni-jena.de: a tool for optimized selection of restriction enzymes for plasmid identification in cloning procedures
Differential digests, also known as test or diagnostic digests, are a standard method in molecular cloning to verify whether a picked clone is indeed the target plasmid or not. However, finding the optimal restriction enzyme for a differential digest by hand may be challenging and time-consuming. To address this problem, we created diffdigester.uni-jena.de (https://diffdigester.uni-jena.de), a free online tool to easily find such enzymes. This tool uses regular expressions to find the restriction sites in the DNA sequences given by the user. It then calculates and displays the resulting fragments on a simulated gel for each enzyme, allowing for easy comparison between the different enzymes. The user can sort these gels alphabetically by enzyme name or by dissimilarity of the restriction patterns between the given DNA sequences. This way, the most distinct pattern is shown first, which gives the most useful enzyme to distinguish between wanted and unwanted ligation products. In fact, it also works on completely unrelated sequences, expanding its possible applications. Thus, diffdigester.uni-jena.de is a fast, reliable, and free-to-use tool to help researchers plan differential digests for verifying their ligation products.
- Open Access
Differential Effects of Hearing Loss Mutations in Homomeric P2X2 and Heteromeric P2X2/3 Receptors
P2X receptors are unspecific cation channels activated by ATP. They are expressed in various tissues and found in neuronal and immune cells. In mammals, seven subunits are described, which can assemble into homomeric and heteromeric trimers. P2X2 receptors play important roles in cochlear adaptation to elevated sound levels. Three mutations causing inherited progressive hearing loss have been identified. These mutations localize to the transmembrane domain 1 (V60L), the transmembrane domain 2 (G353R) and a β-sheet linking the ATP binding site to the pore (D273Y). Herein, mutations were studied in human homomeric P2X2 as well as in heteromeric P2X2/3 receptors. We measured their binding of a fluorescently labeled ATP derivative (fATP) and characterized the constructs using the patch-clamp technique. The conclusions from our results are as follows: 1. The mutations V60L and G353R show robust localization on the plasma membrane and binding of fATP, whereas the mutant D273Y has no binding to fATP. 2. The mutation V60L has an increased affinity to fATP compared with the wildtype. 3. The expression of hP2X2 V60L channels reduces cell viability, which may support its role in the pathogenesis of hearing loss. 4. All mutant P2X2 subunits can assemble into P2X2/3 heteromeric channels with distinct phenotypes.
Open AccessDifferential Effects of Hearing Loss Mutations in Homomeric P2X2 and Heteromeric P2X2/3 Receptors
P2X receptors are unspecific cation channels activated by ATP. They are expressed in various tissues and found in neuronal and immune cells. In mammals, seven subunits are described, which can assemble into homomeric and heteromeric trimers. P2X2 receptors play important roles in cochlear adaptation to elevated sound levels. Three mutations causing inherited progressive hearing loss have been identified. These mutations localize to the transmembrane domain 1 (V60L), the transmembrane domain 2 (G353R) and a β-sheet linking the ATP binding site to the pore (D273Y). Herein, mutations were studied in human homomeric P2X2 as well as in heteromeric P2X2/3 receptors. We measured their binding of a fluorescently labeled ATP derivative (fATP) and characterized the constructs using the patch-clamp technique. The conclusions from our results are as follows: 1. The mutations V60L and G353R show robust localization on the plasma membrane and binding of fATP, whereas the mutant D273Y has no binding to fATP. 2. The mutation V60L has an increased affinity to fATP compared with the wildtype. 3. The expression of hP2X2 V60L channels reduces cell viability, which may support its role in the pathogenesis of hearing loss. 4. All mutant P2X2 subunits can assemble into P2X2/3 heteromeric channels with distinct phenotypes.
- Open Access
- 19 November 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-8
Experts fail to reliably detect AI-generated histological data
AI-based methods to generate images have seen unprecedented advances in recent years challenging both image forensic and human perceptual capabilities. Accordingly, these methods are expected to play an increasingly important role in the fraudulent fabrication of data. This includes images with complicated intrinsic structures such as histological tissue samples, which are harder to forge manually. Here, we use stable diffusion, one of the most recent generative algorithms, to create such a set of artificial histological samples. In a large study with over 800 participants, we study the ability of human subjects to discriminate between these artificial and genuine histological images. Although they perform better than naive participants, we find that even experts fail to reliably identify fabricated data. While participant performance depends on the amount of training data used, even low quantities are sufficient to create convincing images, necessitating methods and policies to detect fabricated data in scientific publications.
- 19 November 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-8
Open AccessExperts fail to reliably detect AI-generated histological data
AI-based methods to generate images have seen unprecedented advances in recent years challenging both image forensic and human perceptual capabilities. Accordingly, these methods are expected to play an increasingly important role in the fraudulent fabrication of data. This includes images with complicated intrinsic structures such as histological tissue samples, which are harder to forge manually. Here, we use stable diffusion, one of the most recent generative algorithms, to create such a set of artificial histological samples. In a large study with over 800 participants, we study the ability of human subjects to discriminate between these artificial and genuine histological images. Although they perform better than naive participants, we find that even experts fail to reliably identify fabricated data. While participant performance depends on the amount of training data used, even low quantities are sufficient to create convincing images, necessitating methods and policies to detect fabricated data in scientific publications.
- Open Access
Experts fail to reliably detect AI-generated histological data
AI-based methods to generate images have seen unprecedented advances in recent years challenging both image forensic and human perceptual capabilities. Accordingly, they are expected to play an increasingly important role in the fraudulent fabrication of data. This includes images with complicated intrinsic structures like histological tissue samples, which are harder to forge manually. We use stable diffusion, one of the most recent generative algorithms, to create such a set of artificial histological samples and in a large study with over 800 participants, we study the ability of human subjects to discriminate between such artificial and genuine histological images. Although they perform better than naive participants, we find that even experts fail to reliably identify fabricated data. While participant performance depends on the amount of training data used, even low quantities result in convincing images, necessitating methods to detect fabricated data and technical standards such as C2PA to secure data integrity.
Open AccessExperts fail to reliably detect AI-generated histological data
AI-based methods to generate images have seen unprecedented advances in recent years challenging both image forensic and human perceptual capabilities. Accordingly, they are expected to play an increasingly important role in the fraudulent fabrication of data. This includes images with complicated intrinsic structures like histological tissue samples, which are harder to forge manually. We use stable diffusion, one of the most recent generative algorithms, to create such a set of artificial histological samples and in a large study with over 800 participants, we study the ability of human subjects to discriminate between such artificial and genuine histological images. Although they perform better than naive participants, we find that even experts fail to reliably identify fabricated data. While participant performance depends on the amount of training data used, even low quantities result in convincing images, necessitating methods to detect fabricated data and technical standards such as C2PA to secure data integrity.
- 6 July 2022
- Published by Wiley in Acta Physiologica
- Vol. 235 (4) , e13852
Mitochondria – More than just batteries for cellular function
- 6 July 2022
- Published by Wiley in Acta Physiologica
- Vol. 235 (4) , e13852
Mitochondria – More than just batteries for cellular function
- Open Access
Toll-like receptor 5 as a novel receptor for fungal zymosan
Microbial pathogens carry specific structural patterns which were termed pathogen-associated molecular patterns (PAMPs). Toll-like receptors (TLRs) as key elements for the recognition of microbial pathogens are necessary for the activation of innate immune pathways. TLRs are activated by binding PAMPs of bacteria, viruses and fungi and initiate a signaling pathway resulting in the activation of transcription factors which modulate the production of various proinflammatory cytokines. It is not fully clear in detail which microbial pattern is recognized by which TLR. Here we show for the first time that TLR5 is a strong receptor for the yeast particle zymosan. We have generated stable human cell lines with combinations of TLR2 and TLR5 knock in/knock out together with stable nuclear factor kappaB (NF-κB) luciferase reporters. We found that both receptors TLR5 and TLR2 lead to an independent activation of the NF-κB pathway when simulated with zymosan. Our results demonstrate that TLR5 is a receptor for the fungal particle zymosan in addition to bacterial fragments like flagellin. Distinct cytokine patterns might suggest that TLR5 is potentially important for the differentiation in the recognition of the specific type of the foreign microorganisms and in the specific host defense response.
Open AccessToll-like receptor 5 as a novel receptor for fungal zymosan
Microbial pathogens carry specific structural patterns which were termed pathogen-associated molecular patterns (PAMPs). Toll-like receptors (TLRs) as key elements for the recognition of microbial pathogens are necessary for the activation of innate immune pathways. TLRs are activated by binding PAMPs of bacteria, viruses and fungi and initiate a signaling pathway resulting in the activation of transcription factors which modulate the production of various proinflammatory cytokines. It is not fully clear in detail which microbial pattern is recognized by which TLR. Here we show for the first time that TLR5 is a strong receptor for the yeast particle zymosan. We have generated stable human cell lines with combinations of TLR2 and TLR5 knock in/knock out together with stable nuclear factor kappaB (NF-κB) luciferase reporters. We found that both receptors TLR5 and TLR2 lead to an independent activation of the NF-κB pathway when simulated with zymosan. Our results demonstrate that TLR5 is a receptor for the fungal particle zymosan in addition to bacterial fragments like flagellin. Distinct cytokine patterns might suggest that TLR5 is potentially important for the differentiation in the recognition of the specific type of the foreign microorganisms and in the specific host defense response.
- Open Access
- 3 December 2021
- Published by Rockefeller University Press in Journal of Cell Biology
- Vol. 221 (1)
pVHL-mediated SMAD3 degradation suppresses TGF-β signaling
Transforming growth factor β (TGF-β) signaling plays a fundamental role in metazoan development and tissue homeostasis. However, the molecular mechanisms concerning the ubiquitin-related dynamic regulation of TGF-β signaling are not thoroughly understood. Using a combination of proteomics and an siRNA screen, we identify pVHL as an E3 ligase for SMAD3 ubiquitination. We show that pVHL directly interacts with conserved lysine and proline residues in the MH2 domain of SMAD3, triggering degradation. As a result, the level of pVHL expression negatively correlates with the expression and activity of SMAD3 in cells, Drosophila wing, and patient tissues. In Drosophila, loss of pVHL leads to the up-regulation of TGF-β targets visible in a downward wing blade phenotype, which is rescued by inhibition of SMAD activity. Drosophila pVHL expression exhibited ectopic veinlets and reduced wing growth in a similar manner as upon loss of TGF-β/SMAD signaling. Thus, our study demonstrates a conserved role of pVHL in the regulation of TGF-β/SMAD3 signaling in human cells and Drosophila wing development.
- 3 December 2021
- Published by Rockefeller University Press in Journal of Cell Biology
- Vol. 221 (1)
Open AccesspVHL-mediated SMAD3 degradation suppresses TGF-β signaling
Transforming growth factor β (TGF-β) signaling plays a fundamental role in metazoan development and tissue homeostasis. However, the molecular mechanisms concerning the ubiquitin-related dynamic regulation of TGF-β signaling are not thoroughly understood. Using a combination of proteomics and an siRNA screen, we identify pVHL as an E3 ligase for SMAD3 ubiquitination. We show that pVHL directly interacts with conserved lysine and proline residues in the MH2 domain of SMAD3, triggering degradation. As a result, the level of pVHL expression negatively correlates with the expression and activity of SMAD3 in cells, Drosophila wing, and patient tissues. In Drosophila, loss of pVHL leads to the up-regulation of TGF-β targets visible in a downward wing blade phenotype, which is rescued by inhibition of SMAD activity. Drosophila pVHL expression exhibited ectopic veinlets and reduced wing growth in a similar manner as upon loss of TGF-β/SMAD signaling. Thus, our study demonstrates a conserved role of pVHL in the regulation of TGF-β/SMAD3 signaling in human cells and Drosophila wing development.
- Open Access
- 25 May 2021
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 49 (W1) , W541-W543
Preselector.uni-jena.de: optimize your cloning—a resource for identifying restriction enzymes for preselection reactions
Preselection digests are a common strategy to reduce the background in the ligation step of molecular cloning. However, choosing fitting restriction enzymes by hand is not trivial and may lead to errors, potentially costing a lot of time and work. We therefore created preselector.uni-jena.de (https://preselector.uni-jena.de/), a free online tool to find such restriction enzymes. The tool uses regular expressions to find recognition sites of restriction enzymes in the DNA sequences provided by the user. This new tool compares the sets of restriction sites and reports the enzymes that cut one sequence but not the other sequences to the user. These enzymes are then the ones suitable for a preselection digest. Thus, preselector.uni-jena.de is a fast, reliable, and free-to-use tool to help researchers designing preselection digestion strategies for their cloning.
- 25 May 2021
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 49 (W1) , W541-W543
Open AccessPreselector.uni-jena.de: optimize your cloning—a resource for identifying restriction enzymes for preselection reactions
Preselection digests are a common strategy to reduce the background in the ligation step of molecular cloning. However, choosing fitting restriction enzymes by hand is not trivial and may lead to errors, potentially costing a lot of time and work. We therefore created preselector.uni-jena.de (https://preselector.uni-jena.de/), a free online tool to find such restriction enzymes. The tool uses regular expressions to find recognition sites of restriction enzymes in the DNA sequences provided by the user. This new tool compares the sets of restriction sites and reports the enzymes that cut one sequence but not the other sequences to the user. These enzymes are then the ones suitable for a preselection digest. Thus, preselector.uni-jena.de is a fast, reliable, and free-to-use tool to help researchers designing preselection digestion strategies for their cloning.